Urinary Tract Infections in Kidney Transplant Recipients
Urinary Tract Infections in Kidney Transplant Recipients
The purpose of this study is to better estimate the prevalence of urinary tract infections
 (UTI) in kidney transplant (KIT) recipients, and especially multidrug resistant (MDR)
 bacteria. KIT recipients have a higher risk of UTI over the 6 first months following the
 transplantation. Urine culture was done in a city lab or at hospital. Current data on
 bacteriuria and candiduria lead mostly to hospital data that are incomplete..
The risk of UTI after a kidney transplantation is higher than in the general population. MDR
 bacteria, such as extended spectrum betalactamase (ESBL)-producing enterobacteriaceae or MDR
 Pseumomoas aeruginosa are emerging threats due to antibiotic selective pressure.
 Epidemiological data are mostly data from hospital laboratories that do not show a complete
 overview of the current situation. In addition, the different centers which participated to
 this study received before the beginning of the study a protocol to avoid carbapenem use. The
 main objective of this study is to assess the prevalence of MDR bacteria in an adult
 population of KIT recipients. Through this study, the management of UTI in KIT recipients
 will be improved. Data on bacteria or yeasts responsible for UTI (identification, resistance
 profile), antibiotic use, patients' outcome, and graft outcome will be collected.
Inclusion criteria

 -  Age ≥ 18 year-old

 -  Kidney transplanted for less than 5 years

 -  First symptomatic episode of UTI with bacteria or yeast

 -  To have a health insurance

 Exclusion criteria

 -  Asymptomatic bacteriuria or candiduria

 -  Protected people

 -  Pregnant women -> 2 bacteria in the urinalysis without external or internal urinary
 catheter